Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Plasma Therapy Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The plasma therapy market has experienced rapid expansion in recent years, with its size projected to increase from $0.61 billion in 2025 to $0.69 billion in 2026, representing a compound annual growth rate (CAGR) of 12.6%. The growth observed during the historical period is largely driven by factors such as limited awareness of the benefits associated with plasma therapy, a continued dependence on conventional treatment methods, an increase in orthopedic and sports medicine procedures, the enhancement of hospital and clinic infrastructure, and early adoption of platelet-rich plasma (PRP) in cosmetic applications.
Market projections for the plasma therapy sector indicate swift expansion in the coming years, with a forecasted rise to $1.13 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.0%. This upward trend during the projection period is driven by advancements in the creation of sophisticated PRP and PRF formulas, heightened activity in regenerative medicine research, a broader range of plasma therapy applications for chronic conditions and cardiac injuries, increased usage in dermatology and dental care, and a surge in clinical trials and research institutions. Key trends shaping this outlook encompass the widespread uptake of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) therapies, the growing scope of regenerative medicine and orthopedic uses, heightened application in dermatology, hair restoration, and plastic surgery, stronger demand for injectable and membrane-based fibrin products, as well as the integration of research initiatives and clinical trials aimed at improving therapeutic results.
Download A Free Sample Report For Comprehensive Market Insights:
Plasma Therapy Market Development Factors: Which Trends Are Supporting Demand?
The increasing prevalence of osteoarthritis is anticipated to fuel growth in the plasma therapy market throughout the forecast period. Platelet-rich plasma (PRP), a form of plasma therapy, is regarded as a secure and effective option for managing osteoarthritis. PRP consists of concentrated autologous growth factors derived from blood, which are injected into the joint to alleviate symptoms by reducing inflammation and decelerating disease progression. For example, a September 2023 report from the Netherlands-based publishing company Elsevier, published in the Journal of Elsevier, projects that by 2050, global osteoarthritis cases will rise by 74.9% (range: 59.4% to 89.9%) for the knee, 48.6% (range: 35.9% to 67.1%) for the hand, 78.6% (range: 57.7% to 105.3%) for the hip, and 95.1% (range: 68.1% to 135.0%) for other types. Common treatments for osteoarthritis include autologous chondrocyte implantation and scaffold implants. Consequently, a higher incidence of osteoarthritis is expected to boost demand for plasma therapy.
Plasma Therapy Market Segments: Where Are The Largest Growth Opportunities?
The plasma therapy market covered in this report is segmented –
1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)
2) By Application: Orthopedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications
3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes
Subsegments:
1) By Pure PRP: High Concentration PRP, Low Concentration PRP
2) By Leukocyte-Rich PRP: PRP With White Blood Cells, PRP With Growth Factors
3) By Pure Platelet-rich Fibrin (PRF): Injectable PRF, Membrane PRF
4) By Leukocyte-rich Fibrin (L-PRF): L-PRF Clots, L-PRF Membranes
Plasma Therapy Market Transformation Trends: Which Innovations Are Driving Change?
Leading companies in the plasma therapy sector are responding to growing demand by rolling out advanced products like the ESG-410 to broaden treatment possibilities. This Electrosurgical Generator is specifically engineered to deliver greater flexibility and efficiency when managing non-muscle-invasive bladder cancer (NMIBC) and benign prostatic hyperplasia (BPH). A notable example occurred in June 2023, when Olympus Corporation, a Japanese medical technology firm, introduced the next-generation ESG-410 device for treating bladder cancer and enlarged prostate. Its design incorporates upgraded capacitors that enhance plasma stability during ignition, ensuring faster activation and more consistent performance compared to the previous ESG-400 model—especially when used with various loop sizes and oval electrodes. By supplying a diverse selection of resection loops, electrodes, and vaporization tools, the ESG-410 offers improved therapeutic options for both NMIBC and BPH.
Plasma Therapy Market Major Participants And Competitive Dynamics
Major companies operating in the plasma therapy market are Takeda Pharmaceutical Company Limited, Bio Products Laboratory Ltd., Arthrex Inc., Biotest AG, China Biologic Products Holdings Inc., DePuy Synthes Companies, CSL Limited, Grifols S.A., Octapharma AG, Terumo BCT Inc., Pfizer Inc., Kedrion Biopharma, ADMA Biologics Inc., SK Plasma Co. Ltd., Kamada Ltd., Fusion HealthCare, LFB Plasma, Baxter International Inc., Bayer AG, GC Biopharma Corp, Hualan Biological Engineering Inc., Japan Blood Products Organization, PlasmaCare Inc., ProMetic Life Sciences Inc., Sanquin, Shanghai RAAS Blood Products Co. Ltd., Canadian Plasma Resources, B Positive Plasma, Proesis Biologics Inc.
Access The Complete Plasma Therapy Market Report:
Plasma Therapy Market Global Footprint: Which Region Holds Market Leadership?
North America was the largest region in the plasma therapy market in 2025. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model